Remarkably, the anticancer actions of soy isoflavones were inhibited in DLD-1 cells, lacking ERβ expression, suggesting that the receptor plays a crucial role in mediating the antiproliferative effects of isoflavones in CRC [103]. The gene discussed is ESR2; the disease is colorectal carcinoma.